These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6193701)

  • 1. Encainide for refractory ventricular tachyarrhythmia.
    Chesnie B; Podrid P; Lown B; Raeder E
    Am J Cardiol; 1983 Sep; 52(5):495-500. PubMed ID: 6193701
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic efficacy of encainide and quinidine: validation of a model for drug assessment.
    Sami M; Harrison DC; Kraemer H; Houston N; Shimasaki C; DeBusk RF
    Am J Cardiol; 1981 Jul; 48(1):147-56. PubMed ID: 6787910
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of encainide for malignant ventricular arrhythmias.
    Tordjman T; Podrid PJ; Raeder E; Lown B
    Am J Cardiol; 1986 Aug; 58(5):87C-95C. PubMed ID: 3092625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of twice daily with thrice daily administered encainide for benign or potentially lethal ventricular arrhythmias.
    Hohnloser SH; Zabel M; Zehender M; Meinertz T; Just H
    Am J Cardiol; 1989 Jan; 63(1):73-6. PubMed ID: 2462343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ventricular arrhythmias in children without structural heart disease with class IC agents as guided by invasive electrophysiology.
    Case CL; Gillette PC
    Am J Cardiol; 1990 Nov; 66(17):1265-6. PubMed ID: 2122708
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
    Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP
    J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation.
    Herre JM; Titus C; Oeff M; Eldar M; Franz MR; Griffin JC; Scheinman MM
    Ann Intern Med; 1990 Nov; 113(9):671-6. PubMed ID: 2121082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to encainide of refractory ventricular tachycardia: clinical application of assays for parent drug and metabolites.
    Anderson JL; Stewart JR; Johnson TA; Lutz JR; Pitt B
    J Cardiovasc Pharmacol; 1982; 4(5):812-9. PubMed ID: 6182414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM; Lee JT; Woosley RL; Echt DS
    Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encainide for cardiac arrhythmias.
    Med Lett Drugs Ther; 1987 May; 29(740):50-2. PubMed ID: 2437434
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical experience of encainide (MJ 9067): a new anti-arrhythmic drug.
    Kesteloot H; Stroobandt R
    Eur J Clin Pharmacol; 1979 Nov; 16(5):323-6. PubMed ID: 93050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
    Roden DM; Reele SB; Higgins SB; Mayol RF; Gammans RE; Oates JA; Woosley RL
    N Engl J Med; 1980 Apr; 302(16):877-82. PubMed ID: 6767186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of oral encainide in frequent and repetitive ventricular arrhythmias.
    Bongiorni MG; Levorato D; Arlotta C; Paperini L; Contini C
    Eur Heart J; 1988 Jul; 9(7):765-76. PubMed ID: 3139413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
    Myerburg RJ; Kessler KM; Cox MM; Huikuri H; Terracall E; Interian A; Fernandez P; Castellanos A
    Circulation; 1989 Dec; 80(6):1571-9. PubMed ID: 2480856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of incessant supraventricular tachycardia by intravenous and oral encainide.
    Brugada P; Abdollah H; Wellens HJ
    J Am Coll Cardiol; 1984 Dec; 4(6):1255-60. PubMed ID: 6438205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole].
    Dumoulin P; Jaillon P; Kher A; Poirier JM; Cheymol G; Valty J; Flammang D; Coumel P; Medvedowsky JL; Barnay C
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():105-9. PubMed ID: 2420299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of encainide in supraventricular arrhythmias.
    Pool PE
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():573-7. PubMed ID: 2125835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of ectopic atrial arrhythmias and premature atrial complexes in adults with encainide.
    Pool PE; Quart BD
    Am J Cardiol; 1988 Dec; 62(19):60L-62L. PubMed ID: 2462340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptoms.
    Horowitz LN
    Am J Cardiol; 1986 Aug; 58(5):83C-86C. PubMed ID: 3092624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequency.
    Duff HJ; Roden DM; Dawson AK; Oates JA; Smith RF; Woosley RL
    Am J Cardiol; 1982 Aug; 50(2):305-12. PubMed ID: 6808820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.